(Q42075063)

16 October 2017

Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis (English)

1 reference

16 October 2017

0 references

1 reference

Zhaohui Xu

2

0 references

Roberto Caputo

object named as

Roberto Caputo

3

0 references

Gabriele Simonini

object named as

Gabriele Simonini

1

0 references

Rolando Cimaz

7

object named as

Rolando Cimaz

1 reference

16 October 2017

Cinzia De Libero

4

1 reference

16 October 2017

Ilaria Pagnini

5

1 reference

16 October 2017

Virginia Pascual

6

1 reference

16 October 2017

language of work or name

1 reference

1 February 2013

1 reference

16 October 2017

Arthritis & Rheumatology

1 reference

16 October 2017

65

1 reference

16 October 2017

2

1 reference

16 October 2017

513-518

1 reference

16 October 2017

Blau syndrome revisited.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

Use of canakinumab in the cryopyrin-associated periodic syndrome

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

CARD15 mutations in Blau syndrome

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3684148

Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2–related disorders Blau syndrome and Crohn disease

17 August 2018

1 reference

12 December 2020

Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene

1 reference

12 December 2020

Pediatric granulomatous arthritis: an international registry

1 reference

12 December 2020

A 4-year-old with a rash

1 reference

12 December 2020

Early onset sarcoidosis: not a benign disease

1 reference

12 December 2020

Interleukin-1beta suppression in Blau syndrome: comment on the article by Martin et al

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.37776

1 reference

16 October 2017

1 reference

16 October 2017

1 reference